# NanoViricides (stock symbol: NNVC) Logo in transparent PNG format

## NanoViricides Logo large

### NanoViricides Logo large Download PNG (600.44 KB)

![NanoViricides Logo large Download PNG (600.44 KB)](/img/orig/NNVC_BIG-908c7267.png)

## NanoViricides Logo icon format

### NanoViricides Logo icon format Download PNG (310.8 KB)

![NanoViricides Logo icon format Download PNG (310.8 KB)](/img/orig/NNVC-4be934e6.png)

## About NanoViricides

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.

1. Website domain: nanoviricides.com
2. Employees: 17
3. Marketcap: $15.47 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
